Capecitabine Plus Pembrolizumab in Patients With Triple Negative Breast Cancer After Chemo-immunotherapy and Surgery

Condition:   Triple Negative Breast Neoplasms Interventions:   Drug: Pembrolizumab injection;   Drug: Capecitabine tablets;   Radiation: Local radiotherapy Sponsor:   UNICANCER Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials